With NXR merger agreement at these price levels, some arbitrage opportunities may exist on ARQ.Downside severely limited by NXS merger offer. Upside relative to AWE aggression and AWE ego.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025